echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Antitumor Therapy > Breast: Olanzapine can effectively prevent nausea and vomiting caused by chemotherapy in Chinese breast cancer patients

    Breast: Olanzapine can effectively prevent nausea and vomiting caused by chemotherapy in Chinese breast cancer patients

    • Last Update: 2021-03-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Adjuvant chemotherapy can improve the treatment effect of patients with early breast cancer , but the nausea and vomiting (CINV) caused by chemotherapy has brought unbearable pain to patients.


    Breast cancer

    The study included 120 patients planned for (new) adjuvant treatment of doxorubicin/cyclophosphamide.


     

    The results showed that in the first cycle of doxorubicin/cyclophosphamide, the "complete response" rate of the olanzapine group was significantly higher than that of the standard group: 65.


    In summary, the results of this study show that adding olanzapine to a standard antiemetic regimen based on apregabalin can better improve CINV.


     

    Original source:

     

    ncbi.


    ncbi.
    nlm.
    nih.
    gov/?term=Yeo+W&cauthor_id=31978815">Yeo Winnie ncbi.
    nlm.
    nih.
    gov/?term=Lau+TK&cauthor_id=31978815">Thomas Lau Kh ncbi.
    nlm.
    nih.
    gov/31978815/" target="_blank" rel="noopener">A randomized Study of the olanzapine-containing versus at The Standard antiemetic regimens for Prevention of Chemotherapy-induced Nausea and vomiting in Chinese Breast Cancer patients in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.